Novo Nordisk

Entidades representativas do setor farmacêutico iniciaram uma campanha para arrecadação de fundos entre suas associadas, como a Novo Nordisk, para ajudar a população afetada pelo maior desastre natural da história do Estado do Rio Grande do Sul. Os valores arrecadados pelas entidades representativas do setor farmacêutico serão transferidos para o Governo do Estado do Rio Grande do Sul. Você também pode ajudar. Doe qualquer quantia pela chave PIX: 92.958.800/0001-38 (CNPJ – SOS Rio Grande do Sul – Banco Banrisul), do Governo do Rio Grande do Sul.

It's International #ClinicalTrialsDay! Thank you to the thousands of participants and to all colleagues for driving scientific innovation and improved patient care. #DrivingChange #Innovation #ICTD2024

What a fantastic #ECO2024, exploring the latest advancements in obesity care. We look forward to seeing you again next year👋 #DrivingChange Catch up on all the highlights from this year's ECO and the latest in obesity related innovations over at Novo Nordisk CongressHub now 👇 https://lnkd.in/d7ANxye4 #Obesity #Innovation

We’re student favourites again! This time we’ve not only been ranked the #1 Most Attractive Employer in Denmark 2024 by students within Engineering/Natural Science, but also within Business and IT! Thank you to all the students who voted for us, it means the world to us to know that future talent sees Novo Nordisk as an attractive employer. We’re always looking to hire talented students, if you are interested in working at Novo Nordisk, explore our early talent career opportunities here: https://brnw.ch/21wJNoD

To understand #obesity, we must understand what is going on in our brains. Click to learn more about the brain’s influence on weight, and why we all gain and maintain weight differently: https://lnkd.in/d3UDXwTz #DrivingChange #Obesity

The #TIME100HEALTH list is out! Our CEO, Lars Fruergaard Jørgensen is featured: “By helping patients with obesity, we now have a dialogue about not just weight but about health and taking the burden off of the health system by preventing a number of co-morbidities related to obesity.” Congratulations to Lars and all the leaders working on novel treatments, fresh discoveries, and cutting-edge innovation!

Our quarterly results are out!    In the first three months of 2024, we have reached more than 41 million people with our diabetes and obesity medicines and taken important steps to defeat serious chronic diseases.    Learn more in the video below or here 👉 https://lnkd.in/gu4MH2U   #NovoNordisk #QuarterlyResults #DrivingChange

We are so proud of you 💙 A huge congratulations to our colleague Lotte Bjerre Knudsen on receiving the Mani L. Bhaumik Breakthrough of the Year Award together with Richard DiMarchi for their leadership in the development of GLP-1 receptor agonists to treat obesity. “In accepting this award, I represent a lot of people who have worked with me and us at Novo Nordisk through many years, including many academic collaborators. I have worked intensely on coming up with ideas and solving problems and in total it has now been exactly 33 years since I started working on GLP-1….I want to send a special message to all girls and women thinking about a career in science, whether it be in academia or in industry. Hopefully my own story can serve as an example and inspire more brilliant female scientific minds to pursue their passion and just go for it!” - Lotte Bjerre Knudsen The award has been established by celebrated physicist Dr. Mani L. Bhaumik and the American Association for the Advancement of Science, and is closely knit together with Science Magazine's Breakthrough of the Year nomination calling out significant scientific advancements.

Join us between 12-15 May at the European Congress on Obesity (#ECO2024)! We'll be rethinking and addressing #obesity for the benefit of the next generation and discussing our groundbreaking 2022 study 'ACTION teens' which explores the perceptions and attitudes towards teenagers living with obesity and the barriers they face to effective care from their caregivers and HCPs. Discover more at Novo Nordisk CongressHub - https://lnkd.in/gmDZgbGX

Half of the world lives in bigger cities, which is also where #obesity, #cardiovasculardisease, and #type2diabetes are rising fastest 👇